Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2026)

Roivant Sciences has reported Other Non-Current Liabilities for 6 years, with the latest figure at $70000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 218.18% year-over-year to $70000.0; the trailing twelve-month figure through Mar 2026 stood at $70000.0 (up 218.18% YoY), and the FY2026 full-year result was $70000.0, up 218.18% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $70000.0, down from $677000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $21.9 million in Q1 2022, with the low at $22000.0 in Q1 2025.
• Historically, Other Non-Current Liabilities has averaged $6.5 million across 5 years, with a median of $2.5 million in 2024.
• Annual changes were most pronounced in 2025 — Other Non-Current Liabilities plunged 99.12% — and 2026, when it soared 218.18%.
• Roivant Sciences' Other Non-Current Liabilities stood at $21.5 million in 2022, then slumped by 79.38% to $4.4 million in 2023, then slumped by 93.07% to $307000.0 in 2024, then surged by 120.52% to $677000.0 in 2025, then plunged by 89.66% to $70000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $70000.0 (Q1 2026), $677000.0 (Q4 2025), and $170000.0 (Q3 2025), per Business Quant data.